Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NF-kB p65 Antikörper (AA 534-538)

Es gibt 1 Publikation für dieses Produkt. Der Kaninchen Polyklonal anti-NF-kB p65 Antikörper wird verwendet zum Nachweis von NF-kB p65 in Proben von Human, Maus und Ratte. Er wurde validiert für WB und IHC.
Produktnummer ABIN362507
268,40 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 10 bis 14 Werktagen

Kurzübersicht für NF-kB p65 Antikörper (AA 534-538) (ABIN362507)

Target

Alle NF-kB p65 (NFkBP65) Antikörper anzeigen
NF-kB p65 (NFkBP65) (Nuclear Factor-kB p65 (NFkBP65))

Reaktivität

  • 525
  • 359
  • 278
  • 41
  • 35
  • 28
  • 24
  • 21
  • 19
  • 15
  • 14
  • 10
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 478
  • 56
  • 2
  • 2
  • 1
Kaninchen

Klonalität

  • 423
  • 116
Polyklonal

Konjugat

  • 281
  • 28
  • 18
  • 13
  • 13
  • 12
  • 12
  • 11
  • 11
  • 11
  • 11
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 6
  • 4
  • 4
  • 2
  • 2
  • 1
Dieser NF-kB p65 Antikörper ist unkonjugiert

Applikation

  • 426
  • 183
  • 169
  • 118
  • 106
  • 105
  • 92
  • 81
  • 69
  • 53
  • 22
  • 8
  • 7
  • 7
  • 6
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 48
    • 31
    • 31
    • 29
    • 26
    • 23
    • 23
    • 20
    • 18
    • 16
    • 15
    • 10
    • 9
    • 9
    • 7
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    AA 534-538

    Spezifität

    The antibody detects endogenous level of total NFkB-p65 protein.

    Aufreinigung

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Immunogen

    Peptide sequence around AA 534-538 (F-S-S-I-A) derived from Human NFkB-p65. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.

    Isotyp

    IgG
  • Applikationshinweise

    Western blotting: 1:500-1:1000
    Immunohistochemistry: 1:50-1:100

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
  • Shah, Dhar, El Zahraa Mohammed, Habtesion, Davies, Jover-Cobos, Macnaughtan, Sharma, Olde Damink, Mookerjee, Jalan: "Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression." in: Journal of hepatology, Vol. 56, Issue 5, pp. 1047-53, (2012) (PubMed).

  • Target

    NF-kB p65 (NFkBP65) (Nuclear Factor-kB p65 (NFkBP65))

    Andere Bezeichnung

    NFkappaB-p65

    Hintergrund

    NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex

    Molekulargewicht

    65 kDa

    NCBI Accession

    NP_001138

    UniProt

    Q04206

    Pathways

    NF-kappaB Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Toll-Like Receptors Cascades, S100 Proteine
Sie sind hier:
Chat with us!